Literature DB >> 11127344

Community control studies on Strongyloides infection in a model island of Okinawa, Japan.

H Toma1, I Shimabukuro, J Kobayashi, T Tasaki, M Takara, Y Sato.   

Abstract

The community control program for Strongyloides infection was conducted by fecal examination and subsequent treatment of the population on a model island (Kume Island) in Okinawa, Japan, for 5 years from 1993 to 1997. More than 1,200 persons, accounting for 17% to 20% of the persons subjected, received fecal examinations each year. The positive rate in 1993 was found to be 9.7% (133/1,374). The positive rate decreased to 6.5% (95/1,468) in 1994, then 4.8% (60/1,245) in 1995, 2.2% (27/1,225) in 1996 and 2.7% (33/1,217) in 1997 through treatment with albendazole or ivermectin on the positive persons detected each year. Among the positive persons detected after operation of the control program, more than 70% were newly detected persons who did not receive an examination in the previous year or were falsely-negative in the previous examination. The low enforcement of procuring fecal examinations, as well as low sensitivity of fecal examination, might have had an effect on the relatively gradual decrease in the prevalence rate, in spite of the high efficacy of the treatment. The results indicate that continuation of the control program for several years is needed to effectively reduce the prevalence of the parasitic infection in the community.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127344

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

1.  Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan.

Authors:  Teruhisa Tanaka; Tetsuo Hirata; Gretchen Parrott; Miwa Higashiarakawa; Takeshi Kinjo; Tetsu Kinjo; Akira Hokama; Jiro Fujita
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

2.  Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases.

Authors:  Daijiro Nabeya; Shusaku Haranaga; Gretchen Lynn Parrott; Takeshi Kinjo; Saifun Nahar; Teruhisa Tanaka; Tetsuo Hirata; Akira Hokama; Masao Tateyama; Jiro Fujita
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

Review 3.  A Community-Directed Integrated Strongyloides Control Program in Queensland, Australia.

Authors:  Adrian Miller; Elizebeth L Young; Valarie Tye; Robert Cody; Melody Muscat; Vicki Saunders; Michelle L Smith; Jenni A Judd; Rick Speare
Journal:  Trop Med Infect Dis       Date:  2018-05-04

4.  Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017.

Authors:  Mitsuru Mukaigawara; Masashi Narita; Soichi Shiiki; Yoshihiro Takayama; Shunichi Takakura; Tomokazu Kishaba
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.